SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020525
Filing Date
2021-04-26
Accepted
2021-04-26 16:00:41
Documents
6
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A cue-def14a_20210609.htm DEF 14A 901393
2 GRAPHIC gs1ikg0u2pqo000005.jpg GRAPHIC 208660
3 GRAPHIC gs1ikg0u2pqo000004.jpg GRAPHIC 604171
4 GRAPHIC gs1ikg0u2pqo000001.jpg GRAPHIC 17679
5 GRAPHIC gs1ikg0u2pqo000003.jpg GRAPHIC 17679
6 GRAPHIC gs1ikg0u2pqo000002.jpg GRAPHIC 17679
  Complete submission text file 0001564590-21-020525.txt   2095275
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38327 | Film No.: 21853740
SIC: 2834 Pharmaceutical Preparations